Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Diseases' platforms in endemic regions
CH-FDJP-CHE110141200-21
EUR 4.52mdeclared budget
EUR 3.52mdisbursed and spent, 984 of 984 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2003 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 4.22m → EUR 4.52m (+7.1%)
- Transactions added: 105 transactions added, EUR 576k
Diseases' platforms in endemic regions · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 907k | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 452k | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 962k | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 415k | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 401k | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 509k | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 574k | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 299k | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 907k | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 452k | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 962k | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 415k | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 401k | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 509k | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 574k | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2021-04-30 | Expenditure | EUR 5,438 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-2-KE | |
| 2021-04-30 | Expenditure | EUR 790 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-3-KE-XM-DAC-7 | |
| 2021-04-30 | Expenditure | EUR 2,086 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-1-US-FR-3 | |
| 2021-04-30 | Expenditure | EUR 1,000 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-2-US | |
| 2021-04-30 | Expenditure | EUR 2,476 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-3-US | |
| 2021-04-30 | Expenditure | EUR 4 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-4-US-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 3,138 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-BR | |
| 2021-05-31 | Expenditure | EUR 1,693 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-BR-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 78 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-3-BR-GB-GOV-1 | |
| 2021-05-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-CD-FR-3 | |
| 2021-05-31 | Expenditure | EUR 500 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-CD | |
| 2021-05-31 | Expenditure | EUR 903 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-CH | |
| 2021-05-31 | Expenditure | EUR 1,739 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-CH | |
| 2021-05-31 | Expenditure | EUR 2,841 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-3-CH-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 1,360 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-4-CH | |
| 2021-05-31 | Expenditure | EUR 6,300 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-ET | |
| 2021-05-31 | Expenditure | EUR 5,000 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-ET-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 4,681 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-KE | |
| 2021-05-31 | Expenditure | EUR 31 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-KE | |
| 2021-05-31 | Expenditure | EUR 24 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-3-KE-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 1,500 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-SD | |
| 2021-05-31 | Expenditure | EUR 5,250 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-2-SD-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 2,580 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-UG-XM-DAC-7 | |
| 2021-05-31 | Expenditure | EUR 974 | Drugs for Neglected Diseases initiative | Expenses - 21-2105-1-US | |
| 2021-06-30 | Expenditure | EUR 2,967 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-1-BR | |
| 2021-06-30 | Expenditure | EUR 3,017 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-2-BR-XM-DAC-7 | |
| 2021-06-30 | Expenditure | EUR 5,636 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-1-CD-FR-3 | |
| 2021-06-30 | Expenditure | EUR 4,657 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-2-CD | |
| 2021-06-30 | Expenditure | EUR 795 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-3-CD | |
| 2021-06-30 | Expenditure | EUR 908 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-1-CH | |
| 2021-06-30 | Expenditure | EUR 1,750 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-2-CH | |
| 2021-06-30 | Expenditure | EUR 1,491 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-3-CH-XM-DAC-7 | |
| 2021-06-30 | Expenditure | EUR 4,628 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-1-KE | |
| 2021-06-30 | Expenditure | EUR 1,027 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-2-KE-XM-DAC-7 | |
| 2021-06-30 | Expenditure | EUR 1,472 | Drugs for Neglected Diseases initiative | Expenses - 21-2106-1-US | |
| 2021-07-31 | Expenditure | EUR 3,375 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-AR | |
| 2021-07-31 | Expenditure | EUR 2,763 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-BR | |
| 2021-07-31 | Expenditure | EUR 3,031 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-2-BR-XM-DAC-7 | |
| 2021-07-31 | Expenditure | EUR -1 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-3-BR-GB-GOV-1 | |
| 2021-07-31 | Expenditure | EUR 2,503 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-CD-FR-3 | |
| 2021-07-31 | Expenditure | EUR 911 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-CH | |
| 2021-07-31 | Expenditure | EUR 350 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-2-CH | |
| 2021-07-31 | Expenditure | EUR 1,754 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-3-CH | |
| 2021-07-31 | Expenditure | EUR 1,495 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-4-CH-XM-DAC-7 | |
| 2021-07-31 | Expenditure | EUR 4,651 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-KE | |
| 2021-07-31 | Expenditure | EUR 10 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-2-KE-XM-DAC-7 | |
| 2021-07-31 | Expenditure | EUR 989 | Drugs for Neglected Diseases initiative | Expenses - 21-2107-1-US | |
| 2021-08-31 | Expenditure | EUR 2,829 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-1-BR | |
| 2021-08-31 | Expenditure | EUR 2,065 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-2-BR-XM-DAC-7 | |
| 2021-08-31 | Expenditure | EUR 3,019 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-1-CD-FR-3 | |
| 2021-08-31 | Expenditure | EUR 24 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-2-CD | |
| 2021-08-31 | Expenditure | EUR 918 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-1-CH | |
| 2021-08-31 | Expenditure | EUR 353 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-2-CH | |
| 2021-08-31 | Expenditure | EUR 1,768 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-3-CH | |
| 2021-08-31 | Expenditure | EUR 1,506 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-4-CH-XM-DAC-7 | |
| 2021-08-31 | Expenditure | EUR 40 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-1-KE | |
| 2021-08-31 | Expenditure | EUR 4,722 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-2-KE-XM-DAC-7 | |
| 2021-08-31 | Expenditure | EUR 1,008 | Drugs for Neglected Diseases initiative | Expenses - 21-2108-1-US | |
| 2021-09-30 | Expenditure | EUR 3,788 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-BR | |
| 2021-09-30 | Expenditure | EUR 2,190 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-2-BR-XM-DAC-7 | |
| 2021-09-30 | Expenditure | EUR 2,256 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-CD-FR-3 | |
| 2021-09-30 | Expenditure | EUR 925 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-CH | |
| 2021-09-30 | Expenditure | EUR 356 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-2-CH | |
| 2021-09-30 | Expenditure | EUR 1,783 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-3-CH | |
| 2021-09-30 | Expenditure | EUR 1,519 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-4-CH-XM-DAC-7 | |
| 2021-09-30 | Expenditure | EUR 1,256 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-KE | |
| 2021-09-30 | Expenditure | EUR 4,696 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-2-KE-XM-DAC-7 | |
| 2021-09-30 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-SD | |
| 2021-09-30 | Expenditure | EUR 5,160 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-UG | |
| 2021-09-30 | Expenditure | EUR 1,013 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-1-US | |
| 2021-09-30 | Expenditure | EUR -2 | Drugs for Neglected Diseases initiative | Expenses - 21-2109-2-US | |
| 2021-10-31 | Expenditure | EUR 1,451 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-BR | |
| 2021-10-31 | Expenditure | EUR 1,442 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-2-BR-XM-DAC-7 | |
| 2021-10-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-CD-FR-3 | |
| 2021-10-31 | Expenditure | EUR 5 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-2-CD | |
| 2021-10-31 | Expenditure | EUR 917 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-CH | |
| 2021-10-31 | Expenditure | EUR 2,271 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-2-CH | |
| 2021-10-31 | Expenditure | EUR 1,960 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-3-CH | |
| 2021-10-31 | Expenditure | EUR 1,505 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-4-CH-XM-DAC-7 | |
| 2021-10-31 | Expenditure | EUR 513 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-KE | |
| 2021-10-31 | Expenditure | EUR 4,871 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-2-KE-XM-DAC-7 | |
| 2021-10-31 | Expenditure | EUR 2,336 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-3-KE | |
| 2021-10-31 | Expenditure | EUR 1,500 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-SD | |
| 2021-10-31 | Expenditure | EUR 1,012 | Drugs for Neglected Diseases initiative | Expenses - 21-2110-1-US | |
| 2021-11-30 | Expenditure | EUR 619 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-BR | |
| 2021-11-30 | Expenditure | EUR 1,390 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-2-BR | |
| 2021-11-30 | Expenditure | EUR 8,526 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-CD-FR-3 | |
| 2021-11-30 | Expenditure | EUR 93 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-2-CD | |
| 2021-11-30 | Expenditure | EUR 167 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-3-CD-XM-DAC-7 | |
| 2021-11-30 | Expenditure | EUR 2,457 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-CH | |
| 2021-11-30 | Expenditure | EUR 358 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-2-CH | |
| 2021-11-30 | Expenditure | EUR 1,792 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-3-CH | |
| 2021-11-30 | Expenditure | EUR 7,200 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-ET | |
| 2021-11-30 | Expenditure | EUR 4,700 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-KE | |
| 2021-11-30 | Expenditure | EUR 828 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-2-KE | |
| 2021-11-30 | Expenditure | EUR 2,134 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-3-KE | |
| 2021-11-30 | Expenditure | EUR 2,580 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-UG | |
| 2021-11-30 | Expenditure | EUR 1,539 | Drugs for Neglected Diseases initiative | Expenses - 21-2111-1-US | |
| 2021-12-31 | Expenditure | EUR 1,686 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-BR | |
| 2021-12-31 | Expenditure | EUR 3,059 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-2-BR | |
| 2021-12-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-CD-FR-3 | |
| 2021-12-31 | Expenditure | EUR 4,436 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-2-CD | |
| 2021-12-31 | Expenditure | EUR 780 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-3-CD | |
| 2021-12-31 | Expenditure | EUR 5,419 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-CH | |
| 2021-12-31 | Expenditure | EUR 665 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-2-CH | |
| 2021-12-31 | Expenditure | EUR 11k | Drugs for Neglected Diseases initiative | Expenses - 21-2112-3-CH | |
| 2021-12-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-KE | |
| 2021-12-31 | Expenditure | EUR 461 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-2-KE | |
| 2021-12-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 21-2112-3-KE | |
| 2021-12-31 | Expenditure | EUR 1,500 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-SD | |
| 2021-12-31 | Expenditure | EUR 1,746 | Drugs for Neglected Diseases initiative | Expenses - 21-2112-1-US | |
| 2023-01-31 | Expenditure | EUR 3,563 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-1-BO | |
| 2021-01-31 | Expenditure | EUR 310 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-1-BR | |
| 2021-01-31 | Expenditure | EUR -6,040 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-2-BR | |
| 2021-01-31 | Expenditure | EUR -6,686 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-3-BR-XM-DAC-7 | |
| 2021-01-31 | Expenditure | EUR -85 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-4-BR-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 1,720 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-1-CD-FR-3 | |
| 2021-01-31 | Expenditure | EUR 714 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-2-CD | |
| 2021-01-31 | Expenditure | EUR -514 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-3-CD | |
| 2021-01-31 | Expenditure | EUR 230 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-4-CD-XM-DAC-7 | |
| 2021-01-31 | Expenditure | EUR 1,167 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-1-CH | |
| 2021-01-31 | Expenditure | EUR 670 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-2-CH-GB-GOV-1 | |
| 2021-01-31 | Expenditure | EUR 4,536 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-1-KE | |
| 2021-01-31 | Expenditure | EUR 643 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-2-KE | |
| 2021-01-31 | Expenditure | EUR 1,643 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-3-KE-XM-DAC-7 | |
| 2021-01-31 | Expenditure | EUR 218 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-4-KE | |
| 2021-01-31 | Expenditure | EUR 7 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 15 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-2-US | |
| 2021-01-31 | Expenditure | EUR 988 | Drugs for Neglected Diseases initiative | Expenses - 21-2101-3-US-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 1,317 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-BR-XM-DAC-7 | |
| 2021-02-28 | Expenditure | EUR 1,889 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-2-BR-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 7,887 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-CD-FR-3 | |
| 2021-02-28 | Expenditure | EUR 72 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-2-CD | |
| 2021-02-28 | Expenditure | EUR 695 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-CH | |
| 2021-02-28 | Expenditure | EUR 1,729 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-2-CH-XM-DAC-7 | |
| 2021-02-28 | Expenditure | EUR 1,570 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-3-CH-GB-GOV-1 | |
| 2021-02-28 | Expenditure | EUR 5,709 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-KE | |
| 2021-02-28 | Expenditure | EUR -1,006 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-2-KE-XM-DAC-7 | |
| 2021-02-28 | Expenditure | EUR 289 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-3-KE | |
| 2021-02-28 | Expenditure | EUR 5,250 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-SD-XM-DAC-7 | |
| 2021-02-28 | Expenditure | EUR 4 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-1-US | |
| 2021-02-28 | Expenditure | EUR 1,156 | Drugs for Neglected Diseases initiative | Expenses - 21-2102-2-US-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 162 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-BR | |
| 2021-03-31 | Expenditure | EUR 712 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-2-BR-XM-DAC-7 | |
| 2021-03-31 | Expenditure | EUR 1,270 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-3-BR-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 2,678 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-CD-FR-3 | |
| 2021-03-31 | Expenditure | EUR 368 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-2-CD | |
| 2021-03-31 | Expenditure | EUR 917 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-CH | |
| 2021-03-31 | Expenditure | EUR 1,506 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-2-CH-XM-DAC-7 | |
| 2021-03-31 | Expenditure | EUR 1,767 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-3-CH-GB-GOV-1 | |
| 2021-03-31 | Expenditure | EUR 5,527 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-KE | |
| 2021-03-31 | Expenditure | EUR 13 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-2-KE-XM-DAC-7 | |
| 2021-03-31 | Expenditure | EUR 708 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-3-KE | |
| 2021-03-31 | Expenditure | EUR 1,500 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-SD-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR -3,290 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-1-BR | |
| 2023-01-31 | Expenditure | EUR 3,010 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-2-BR | |
| 2023-01-31 | Expenditure | EUR 498 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-3-BR | |
| 2023-01-31 | Expenditure | EUR 160 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-4-BR-GB-GOV-1 | |
| 2023-01-31 | Expenditure | EUR -1,436 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-1-CD | |
| 2023-01-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 21-2301-2-CD-FR-3 | |
| 2023-01-31 | Expenditure | EUR 2,202 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-3-CD | |
| 2023-01-31 | Expenditure | EUR 505 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-4-CD-NO-BRC-971277882 | |
| 2023-01-31 | Expenditure | EUR 1,654 | Drugs for Neglected Diseases initiative | Expenses - 21-2301-1-CH | |
| 2023-02-28 | Expenditure | EUR 360 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-1-BR | |
| 2023-02-28 | Expenditure | EUR 3,032 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-2-BR | |
| 2023-02-28 | Expenditure | EUR 608 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-3-BR | |
| 2023-02-28 | Expenditure | EUR 696 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-1-CD | |
| 2023-02-28 | Expenditure | EUR 3,921 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-2-CD-FR-3 | |
| 2023-02-28 | Expenditure | EUR 4,075 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-3-CD | |
| 2023-02-28 | Expenditure | EUR 26k | Drugs for Neglected Diseases initiative | Expenses - 21-2302-4-CD-NO-BRC-971277882 | |
| 2023-02-28 | Expenditure | EUR 1,639 | Drugs for Neglected Diseases initiative | Expenses - 21-2302-1-CH | |
| 2023-03-31 | Expenditure | EUR 626 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-1-BR | |
| 2023-03-31 | Expenditure | EUR 3,084 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-2-BR | |
| 2023-03-31 | Expenditure | EUR 879 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-3-BR | |
| 2023-03-31 | Expenditure | EUR 983 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-1-CD | |
| 2023-03-31 | Expenditure | EUR 889 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-2-CD-FR-3 | |
| 2023-03-31 | Expenditure | EUR 5,588 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-3-CD | |
| 2023-03-31 | Expenditure | EUR 6,785 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-4-CD-NO-BRC-971277882 | |
| 2023-03-31 | Expenditure | EUR 1,671 | Drugs for Neglected Diseases initiative | Expenses - 21-2303-1-CH | |
| 2023-03-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 21-2303-1-GB-XM-DAC-7 | |
| 2023-04-30 | Expenditure | EUR 3,655 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-1-BO | |
| 2023-04-30 | Expenditure | EUR 1,625 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-1-BR | |
| 2023-04-30 | Expenditure | EUR 569 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-2-BR | |
| 2023-04-30 | Expenditure | EUR 3,182 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-3-BR-GB-GOV-1 | |
| 2023-04-30 | Expenditure | EUR 525 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-1-CD | |
| 2023-04-30 | Expenditure | EUR 3,301 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-2-CD-FR-3 | |
| 2023-04-30 | Expenditure | EUR 3 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-3-CD-NO-BRC-971277882 | |
| 2023-04-30 | Expenditure | EUR 1,675 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-1-CH | |
| 2023-04-30 | Expenditure | EUR 2,246 | Drugs for Neglected Diseases initiative | Expenses - 21-2304-1-US | |
| 2023-05-31 | Expenditure | EUR 563 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-1-BR | |
| 2023-05-31 | Expenditure | EUR 1,187 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-2-BR | |
| 2023-05-31 | Expenditure | EUR 3,473 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-3-BR-GB-GOV-1 | |
| 2023-05-31 | Expenditure | EUR 1,563 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-1-CD | |
| 2023-05-31 | Expenditure | EUR 3,170 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-2-CD-FR-3 | |
| 2023-05-31 | Expenditure | EUR 406 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-3-CD-NO-BRC-971277882 | |
| 2023-05-31 | Expenditure | EUR 1,683 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-1-CH | |
| 2023-05-31 | Expenditure | EUR 666 | Drugs for Neglected Diseases initiative | Expenses - 21-2305-1-US | |
| 2023-06-30 | Expenditure | EUR 4,840 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-1-BO | |
| 2023-06-30 | Expenditure | EUR 551 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-1-BR | |
| 2023-06-30 | Expenditure | EUR 978 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-2-BR | |
| 2023-06-30 | Expenditure | EUR 3,440 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-3-BR-GB-GOV-1 | |
| 2023-06-30 | Expenditure | EUR 2,327 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-1-CD | |
| 2023-06-30 | Expenditure | EUR 8,271 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-2-CD-FR-3 | |
| 2023-06-30 | Expenditure | EUR 415 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-3-CD | |
| 2023-06-30 | Expenditure | EUR 401 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-4-CD-NO-BRC-971277882 | |
| 2023-06-30 | Expenditure | EUR 1,701 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-1-CH | |
| 2023-06-30 | Expenditure | EUR 737 | Drugs for Neglected Diseases initiative | Expenses - 21-2306-1-FR | |
| 2023-07-31 | Expenditure | EUR 547 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-1-BR | |
| 2023-07-31 | Expenditure | EUR 3,702 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-2-BR | |
| 2023-07-31 | Expenditure | EUR 876 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-3-BR | |
| 2023-07-31 | Expenditure | EUR 3,712 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-1-CD | |
| 2023-07-31 | Expenditure | EUR 415 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-2-CD | |
| 2023-07-31 | Expenditure | EUR 2,120 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-3-CD-NO-BRC-971277882 | |
| 2023-07-31 | Expenditure | EUR 1,698 | Drugs for Neglected Diseases initiative | Expenses - 21-2307-1-CH | |
| 2023-08-31 | Expenditure | EUR 547 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-1-BR | |
| 2023-08-31 | Expenditure | EUR 5,968 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-2-BR | |
| 2023-08-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 21-2308-3-BR | |
| 2023-08-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 21-2308-1-CD | |
| 2023-08-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 21-2308-2-CD | |
| 2023-08-31 | Expenditure | EUR 582 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-3-CD | |
| 2023-08-31 | Expenditure | EUR 932 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-4-CD-NO-BRC-971277882 | |
| 2023-08-31 | Expenditure | EUR 1,717 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-1-CH | |
| 2023-08-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 21-2308-1-GB | |
| 2023-08-31 | Expenditure | EUR 971 | Drugs for Neglected Diseases initiative | Expenses - 21-2308-1-US | |
| 2023-09-30 | Expenditure | EUR 572 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-BR | |
| 2023-09-30 | Expenditure | EUR 4,010 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-2-BR | |
| 2023-09-30 | Expenditure | EUR 7,982 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-3-BR | |
| 2023-09-30 | Expenditure | EUR 20 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-4-BR-GB-GOV-1 | |
| 2023-09-30 | Expenditure | EUR -4,002 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-CD | |
| 2023-09-30 | Expenditure | EUR 8,571 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-2-CD | |
| 2023-09-30 | Expenditure | EUR 103 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-3-CD-NO-BRC-971277882 | |
| 2023-09-30 | Expenditure | EUR 1,730 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-CH | |
| 2023-09-30 | Expenditure | EUR 532 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-GB | |
| 2023-09-30 | Expenditure | EUR 710 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-KE | |
| 2023-09-30 | Expenditure | EUR 544 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-1-US | |
| 2023-09-30 | Expenditure | EUR 2,365 | Drugs for Neglected Diseases initiative | Expenses - 21-2309-2-US | |
| 2023-10-31 | Expenditure | EUR 4,247 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-1-BO | |
| 2023-10-31 | Expenditure | EUR 555 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-1-BR | |
| 2023-10-31 | Expenditure | EUR 5,508 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-2-BR | |
| 2023-10-31 | Expenditure | EUR 6,082 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-3-BR | |
| 2023-10-31 | Expenditure | EUR 4,508 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-1-CD | |
| 2023-10-31 | Expenditure | EUR 422 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-2-CD | |
| 2023-10-31 | Expenditure | EUR 509 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-3-CD-NO-BRC-971277882 | |
| 2023-10-31 | Expenditure | EUR 1,793 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-1-CH | |
| 2023-10-31 | Expenditure | EUR 486 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-2-CH | |
| 2023-10-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 21-2310-1-US | |
| 2023-10-31 | Expenditure | EUR 3,068 | Drugs for Neglected Diseases initiative | Expenses - 21-2310-2-US | |
| 2023-11-30 | Expenditure | EUR 552 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-1-BR | |
| 2023-11-30 | Expenditure | EUR 3,593 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-2-BR | |
| 2023-11-30 | Expenditure | EUR 2,869 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-3-BR | |
| 2023-11-30 | Expenditure | EUR 6,949 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-1-CD | |
| 2023-11-30 | Expenditure | EUR 1,479 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-2-CD | |
| 2023-11-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 21-2311-3-CD | |
| 2023-11-30 | Expenditure | EUR 1,671 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-4-CD-NO-BRC-971277882 | |
| 2023-11-30 | Expenditure | EUR 1,736 | Drugs for Neglected Diseases initiative | Expenses - 21-2311-1-CH | |
| 2023-12-31 | Expenditure | EUR 7,418 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-1-BR | |
| 2023-12-31 | Expenditure | EUR 7,612 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-2-BR | |
| 2023-12-31 | Expenditure | EUR 6,269 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-3-BR | |
| 2023-12-31 | Expenditure | EUR 7,074 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-1-CD | |
| 2023-12-31 | Expenditure | EUR 36k | Drugs for Neglected Diseases initiative | Expenses - 21-2312-2-CD | |
| 2023-12-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 21-2312-3-CD-NO-BRC-971277882 | |
| 2023-12-31 | Expenditure | EUR 2,431 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-1-CH | |
| 2023-12-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 21-2312-1-GB | |
| 2023-12-31 | Expenditure | EUR 2,005 | Drugs for Neglected Diseases initiative | Expenses - 21-2312-1-US | |
| 2020-06-30 | Expenditure | EUR 2,694 | Drugs for Neglected Diseases initiative | Expenses - 21-2006-1-BR | |
| 2021-03-31 | Expenditure | EUR 5 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-1-US | |
| 2021-03-31 | Expenditure | EUR 985 | Drugs for Neglected Diseases initiative | Expenses - 21-2103-2-US-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 2,118 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-1-BR | |
| 2021-04-30 | Expenditure | EUR 1,382 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-2-BR-XM-DAC-7 | |
| 2021-04-30 | Expenditure | EUR -4 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-3-BR-GB-GOV-1 | |
| 2021-04-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 21-2104-1-CD-FR-3 | |
| 2021-04-30 | Expenditure | EUR 2,634 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-1-CH | |
| 2021-04-30 | Expenditure | EUR 1,477 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-2-CH-XM-DAC-7 | |
| 2021-04-30 | Expenditure | EUR 5,070 | Drugs for Neglected Diseases initiative | Expenses - 21-2104-1-KE | |
| 2022-01-31 | Expenditure | EUR -501 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-1-BR | |
| 2022-01-31 | Expenditure | EUR -4 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-2-BR | |
| 2022-01-31 | Expenditure | EUR 1,064 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-3-BR | |
| 2022-01-31 | Expenditure | EUR 999 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-4-BR | |
| 2022-01-31 | Expenditure | EUR 2,041 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-1-CD-FR-3 | |
| 2022-01-31 | Expenditure | EUR 91 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-2-CD | |
| 2022-01-31 | Expenditure | EUR 1,092 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-1-CH-FR-3 | |
| 2022-01-31 | Expenditure | EUR 599 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-2-CH | |
| 2022-01-31 | Expenditure | EUR 184 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-3-CH-GB-GOV-1 | |
| 2022-01-31 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-1-US | |
| 2022-01-31 | Expenditure | EUR 531 | Drugs for Neglected Diseases initiative | Expenses - 21-2201-2-US | |
| 2022-02-28 | Expenditure | EUR 1,492 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-1-BR | |
| 2022-02-28 | Expenditure | EUR 865 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-2-BR | |
| 2022-02-28 | Expenditure | EUR 4,538 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-1-CD-FR-3 | |
| 2022-02-28 | Expenditure | EUR 43 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-2-CD | |
| 2022-02-28 | Expenditure | EUR 184 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-1-CH | |
| 2022-02-28 | Expenditure | EUR 956 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-2-CH | |
| 2022-02-28 | Expenditure | EUR 1,569 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-3-CH | |
| 2022-02-28 | Expenditure | EUR 318 | Drugs for Neglected Diseases initiative | Expenses - 21-2202-1-US | |
| 2022-03-31 | Expenditure | EUR 1,558 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-1-BR | |
| 2022-03-31 | Expenditure | EUR 2,933 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-2-BR | |
| 2022-03-31 | Expenditure | EUR 321 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-1-CD-FR-3 | |
| 2022-03-31 | Expenditure | EUR 28 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-2-CD | |
| 2022-03-31 | Expenditure | EUR 2,969 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-3-CD | |
| 2022-03-31 | Expenditure | EUR 950 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-1-CH | |
| 2022-03-31 | Expenditure | EUR 1,824 | Drugs for Neglected Diseases initiative | Expenses - 21-2203-2-CH |
Showing 300 of 984. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.